Ikarovec
PITCH
Ikarovec is a pre-clinical phase gene therapy company. Our programmes are aimed at treating common eye diseases. Our technology allows for targeting multiple disease targets and pathways thereby improving efficacy and restoring sight and preventing blindness.
LATEST INVESTMENT
#biotech
06.2020
Ikarovec
£458K
Innovate UK